BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/5/2020 10:12:50 AM | Browse: 674 | Download: 1987
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 54189
Country Egypt
Received
2020-01-14 05:37
Peer-Review Started
2020-01-14 05:37
First Decision by Editorial Office Director
2020-04-18 16:50
Return for Revision
2020-04-21 13:49
Revised
2020-05-28 11:16
Publication Fee Transferred
Second Decision by Editor
2020-06-29 09:25
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2020-07-01 22:31
Articles in Press
2020-07-01 22:31
Edit the Manuscript by Language Editor
2020-07-13 06:46
Typeset the Manuscript
2020-07-22 04:48
Publish the Manuscript Online
2020-08-05 09:37
ISSN 2150-5349 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country
Manuscript Source Invited Manuscript
All Author List Mortada HF El-Shabrawi, Sara Tarek, Maha Abou-Zekri, Safa Meshaal, Afaf Enayet and Engy Adel Mogahed
Funding Agency and Grant Number
Corresponding Author Mortada HF El-Shabrawi, MD, Professor, Department of Paediatrics, Kasr Alainy School of Medicine, Cairo University, 1 Gamaa Street, Giza, Cairo 11562, Egypt. melshabrawi@kasralainy.edu.eg
Key Words Children; Crohn's disease; Egypt; Elevated liver enzymes; Hepatobiliary; Inflammatory bowel disease
Core Tip The incidence of inflammatory bowel disease (IBD) in children was increased recently worldwide. Likewise, the reported incidence of the hepatobiliary (HB) manifestations of IBD in developed countries is rising, while in low- and middle-income countries, there are no much available reports especially in the paediatric age group. In this cohort of Egyptian children with IBD, all patients were screened for HB disorders by physical examination, biochemical tests of liver functions, imaging and liver biopsy when indicated. The most frequently reported HB disorders in our children with IBD are abnormal biochemical liver function tests, fatty infiltration and primary sclerosing cholangitis.
Publish Date 2020-08-05 09:37
Citation El-Shabrawi MHF, Tarek S, Abou-Zekri M, Meshaal S, Enayet A, Mogahed EA. Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country. World J Gastrointest Pharmacol Ther 2020; 11(3): 48-58
URL https://www.wjgnet.com/2150-5349/full/v11/i3/48.htm
DOI https://dx.doi.org/10.4292/wjgpt.v11.i3.48
Full Article (PDF) WJGPT-11-48.pdf
Full Article (Word) WJGPT-11-48.docx